SCHEMBL9970933

SCHEMBL9970933

CC(C)c1ccc(-c2ccccc2Cl)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RAB9A P51151 8/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 5/20 0.43
MAPT P10636 5/20 0.43
MAPK1 P28482 4/20 0.43
LMNA P02545 4/20 0.43
HPGD P15428 3/20 0.43
CASP3 P42574 2/20 0.43
SENP7 Q9BQF6 2/20 0.43
SLC9A1 P19634 1/20 0.43
RECQL P46063 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
HSD17B10 Q99714 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13808613 0.82 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL21119020 0.79 MAPT (0.56) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL13809597 0.79 S1PR4 (0.52) ALDH1A1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL13809598 0.78 NPFFR1 (0.44) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL12261863 0.78 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL9970934 0.77 AMY1A (0.47) ALDH1A1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL1616485 0.76 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL13718652 0.75 MAPT (0.48) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL19237535 0.73 S1PR4 (0.47) ALDH1A1MEN1KMT2ANPSR1RAB9A
SCHEMBL5543164 0.72 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ANPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones DHPS, FDPS, DPYD ALDH1A1 333/4885MEN1 3414/4885KMT2A 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.